Study outcomes
jaundice, death, fever, cholangitis
RECURRENT CHOLANGITIS, CHOLANGITIS
Demographic characteristics and clinical characteristics were assessed, including gender, age, body weight, age at KPE, age at the first episode of cholangitis, body temperature, duration of fever subsided to normal (DOF) and length of hospital stay (LOS). Laboratory assessments included WBC, CRP, alanine aminotransferase (ALT), aspartate aminotransferase (AST), DBIL, gamma-glutamyl transferase (γ-GGT), and bacterial culture before the intervention. Follow-up visits were scheduled at 1, 3, and 6 months after discharge. The study endpoint was defined as: completion of 6-month follow-up; liver transplantation; death.The primary outcome was DOF. If patients had a normal temperature after antipyretic therapy on admission, DOF was recorded as the time from admission to fever resolution. Secondary outcomes included blood culture, LOS, incidence of recurrent cholangitis, jaundice clearance, and native liver survival (NLS) at 1, 3, and 6 months